- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of December 2018
Here are the top 5 articles for the month of December.
Hi, I'm Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of December.
Number 5: Competing breast cancer tests vied for attention from clinicians and payers at the San Antonio Breast Cancer Symposium.
Number 4: While the Oncology Care Model is likely not a sustainable model for oncology care, it will probably inform what structure comes next, according to Michael Kolodziej, MD, vice president and chief innovation officer, ADVI Health.
Number 3: A new study is adding to the debate of statin use to prevent cardiovascular disease, arguing that the benefits don't outweigh the harms.
Number 2: A federal judge in Texas ruled that the Affordable Care Act's individual mandata is unconstitutional and that the rest of the law must also fall.
Number 1: New reports from the CDC highlight troubling increasing trends in suicides and drug overdose rates as life expectancy in the United States declined for the second year in a row.
To read all of these articles and more, visit AJMC.com.
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
August 19th 2025Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More
